Recall: D-0246-2021

Class II - Potentially Harmful

Class IIClassification

2021-01-08Initiated

TerminatedStatus

Taro Pharmaceuticals U.S.A., IFirm

Product

Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1

Reason

CGMP deviations.

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.